Return to study ST000963 main page

MB Sample ID: SA057657

Local Sample ID:DS_38
Subject ID:SU001002
Subject Type:Mammal
Subject Species:Rattus norvegicus
Taxonomy ID:10116
Genotype Strain:Fisher rat
Age Or Age Range:10-week-old
Weight Or Weight Range:not measured
Height Or Height Range:not measured
Gender:Male
Animal Animal Supplier:Charles River
Animal Housing:standard
Animal Light Cycle:standard 12 h
Animal Feed:standard grain-based
Animal Water:standard unlimited
Animal Inclusion Criteria:random
Species Group:-

Select appropriate tab below to view additional metadata details:


Subject:

Subject ID:SU001002
Subject Type:Mammal
Subject Species:Rattus norvegicus
Taxonomy ID:10116
Genotype Strain:Fisher rat
Age Or Age Range:10-week-old
Weight Or Weight Range:not measured
Height Or Height Range:not measured
Gender:Male
Animal Animal Supplier:Charles River
Animal Housing:standard
Animal Light Cycle:standard 12 h
Animal Feed:standard grain-based
Animal Water:standard unlimited
Animal Inclusion Criteria:random
Species Group:-

Factors:

Local Sample IDMB Sample IDFactor Level IDLevel ValueFactor Name
DS_38SA057657FL010375naïve controlTreatment

Collection:

Collection ID:CO000996
Collection Summary:Experimental groups consisted of naïve controls (control), ON crush + intravitreal Zymosan + CPT-cAMP (regeneration), and ON crush + intravitreal vehicle (crush). Retinas were harvested on day 7 and 14 and ON were harvested on day 3, 7 and 14 post-crush.
Collection Protocol Comments:retina and optic nerves collected
Sample Type:Eye tissue
Collection Frequency:day 3, 7 and 14 post-crush
Storage Conditions:-80℃
Collection Vials:1.5 mL polypropylene tubes
Storage Vials:1.5 mL polypropylene tubes

Treatment:

Treatment ID:TR001016
Treatment Summary:A rat model of inflammation-induced ON regeneration was established by intravitreal injection of a yeast cell wall preparation (Zymosan A) and a cell permeant CPT-cAMP, immediately after ON crush. Ten-week-old male Fischer rats were deeply anesthetized with inhaled isoflurane, and the eyes were treated with topical anesthetic (proparacaine HCl 0.5% ophthalmic) and a cycloplegic (tropicamide 0.5% ophthalmic) to reduce pain and assist with visualization of intravitreal injections. The left ON was exposed by blunt dissection through a temporal, fornix-based conjunctival incision and crushed for 10 seconds with Dumoxel #N5 self-closing forceps (Dumont, Montignez, Switzerland). Absence of injury to the retinal vascular supply was confirmed by post-crush funduscopic examination. Intravitreal injections (5 µL) of PBS vehicle or a suspension of finely ground, sterilized Zymosan A (Z4250; Sigma-Aldrich, St. Louis, MO, USA; 12.5 mg/mL) plus CPT-cAMP (C3912; Sigma-Aldrich, St. Louis, MO, USA; 100 µM) were performed with a pulled glass pipette attached to a Hamilton syringe on a manual micromanipulator. Injections were made 2 mm posterior to the limbus, and care was taken to prevent lens injury, choroidal hemorrhage, or retinal detachment. Absence of these intraocular adverse events was confirmed by fundoscopic examination. Conjunctival incisions were closed with 8-0 vicryl sutures and petrolatum ophthalmic ointment was applied to the ocular surface.

Sample Preparation:

Sampleprep ID:SP001009
Sampleprep Summary:Specimens were stored at -80ºC. Before extraction, ON and retinas were cut into ~1 mm3 pieces. 6 mL of methanol (LC-MS grade) and 3 mL of chloroform (LC-MS grade) were added to each sample. For this high throughput approach, no internal standards were added to samples. After 2 min vigorous vortexing and 2 min sonication in ultrasonic bath, the samples were incubated at 48ºC overnight (in borosilicate glass vials, PTFE-lined caps). The following day, 3 mL of water (LC-MS grade) and 1.5 mL of chloroform were added, samples vigorously vortexed for 2 min and centrifuged at 3000 RCF, 4ºC for 15 min to obtain phase separation. Lower phases were collected and dried in a centrifugal vacuum concentrator. Samples were stored at -20ºC until reconstituted in 60 µL of chloroform:methanol (1:1) prior to mass spectrometric analysis.
Sampleprep Protocol Filename:method.docx
Processing Method:lipid extraction
Processing Storage Conditions:Described in summary
Extract Storage:-20℃
Sample Spiking:no internal standards added

Combined analysis:

Analysis ID AN001577
Analysis type MS
Chromatography type Reversed phase
Chromatography system Thermo Accela 600
Column Thermo Acclaim C30 (150 x 2.1mm,3um)
MS Type ESI
MS instrument type Orbitrap
MS instrument name Thermo Q Exactive Orbitrap
Ion Mode UNSPECIFIED
Units peak area

Chromatography:

Chromatography ID:CH001106
Chromatography Summary:Reversed phase chromatographic separation was achieved using Accela Autosampler, Accela 600 pump and Acclaim C30 column: 3 µm, 2.1x150 mm (Thermo Fisher Scientific, Waltham, MA). The column temperature was maintained at 30 ºC (negative mode) or 45ºC (positive mode) and tray temperature at 20ºC. Solvent A was composed of 10 mM ammonium acetate (LC-MS grade) in 60:40 methanol:water (LC-MS grade) with 0.2% formic acid (LC-MS grade). Solvent B was composed of 10 mM ammonium acetate with 60:40 methanol:chloroform with 0.2% formic acid. The flow rate was 260 µL/min and injection volume was 5 µL. The gradient was 35-100% solvent B over 13.0 min, 100% solvent B over 13.0-13.8 min, 100-35% solvent B over 13.8-14.5 min, 35% solvent B over 14.5-18.0 min, 0% solvent B over 18.0-20.0 min.
Instrument Name:Thermo Accela 600
Column Name:Thermo Acclaim C30 (150 x 2.1mm,3um)
Column Temperature:30 (negative mode)/45 (positive mode)
Flow Gradient:The gradient was 35-100% solvent B over 13.0 min, 100% solvent B over 13.0-13.8 min, 100-35% solvent B over 13.8-14.5 min, 35% solvent B over 14.5-18.0 min, 0% solvent B over 18.0-20.0 min.
Flow Rate:260 µL/min
Sample Injection:5 µL
Solvent A:60% methanol/40% water; 0.2% formic acid; 10 mM ammonium acetate
Solvent B:60% methanol/40% chloroform; 0.2% formic acid; 10 mM ammonium acetate
Analytical Time:20 min
Oven Temperature:20ºC
Chromatography Type:Reversed phase

MS:

MS ID:MS001455
Analysis ID:AN001577
Instrument Name:Thermo Q Exactive Orbitrap
Instrument Type:Orbitrap
MS Type:ESI
Ion Mode:UNSPECIFIED
Capillary Temperature:310ºC (negative mode) or 350ºC (positive mode)
Collision Energy:40±30% for the negative mode and 30, parallel with 19±5% for the positive mode
Ionization:+/-
Spray Voltage:4.4 kV
Automatic Gain Control:MS: 1x106; MS/MS: 2x105 (negative mode) or 1x105 (positive mode)
Dataformat:.RAW
Resolution Setting:MS: 70,000; MS/MS: 17,500
  logo